Literature DB >> 18540742

A meta-analysis of controlled research on social skills training for schizophrenia.

Matthew M Kurtz1, Kim T Mueser.   

Abstract

A meta-analysis of randomized, controlled trials of social skills training for schizophrenia was conducted. Outcome measures from 22 studies including 1,521 clients were categorized according to a proximal-distal continuum in relation to the presumed site of action of skills training interventions, with content mastery tests and performance-based measures of skills assumed to be most proximal, community functioning and negative symptoms intermediate, and general symptoms and relapse most distal. Results reveal a large weighted mean effect size for content-mastery exams (d = 1.20), a moderate mean effect size for performance-based measures of social and daily living skills (d = 0.52), moderate mean effect sizes for community functioning (d = 0.52) and negative symptoms (d = 0.40), and small mean effect sizes for other symptoms (d = 0.15) and relapse (d = 0.23). These results support the efficacy of social skills training for improving psychosocial functioning in schizophrenia. (c) 2008 APA, all rights reserved

Entities:  

Mesh:

Year:  2008        PMID: 18540742     DOI: 10.1037/0022-006X.76.3.491

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  82 in total

1.  Expectancy-value theory in persistence of learning effects in schizophrenia: role of task value and perceived competency.

Authors:  Jimmy Choi; Joanna M Fiszdon; Alice Medalia
Journal:  Schizophr Bull       Date:  2010-07-15       Impact factor: 9.306

Review 2.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

Review 3.  [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].

Authors:  S G Riedel-Heller; U Gühne; S Weinmann; K Arnold; E-S Ay; T Becker
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

4.  [Integrating psychotherapeutic treatment of severe mental illness: between desirability and clinical practice].

Authors:  M Pfammatter; U M Junghan
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

5.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

Review 6.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

7.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

8.  Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort.

Authors:  Danielle Cornacchio; Amy E Pinkham; David L Penn; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-09-29       Impact factor: 4.939

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

10.  Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ).

Authors:  Isabelle Lanser; Julia Browne; Amy E Pinkham; Philip D Harvey; L Fredrik Jarskog; David L Penn
Journal:  Psychiatry Res       Date:  2018-08-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.